BCL2L11 and cancer: First, BCL-2 family members, which regulate the commitment to mitochondrial apoptosis by balancing pro-apoptotic proteins such as BAD and BIM, and anti-apoptotic proteins such as BCL-2 or MCL-1 [20], have been shown to contribute to the formation, progression, and therapeutic response in breast and other cancers [21, 88].